CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- 8-K Event Results of operations
- 4 Shares withheld for taxes Director gave up 1,088 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 1,088 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Operating Officer gave up 11,007 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Shares withheld for taxes Director and CEO, Alkermes plc gave up 91,757 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Commercial Officer gave up 8,135 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Corp Dev., Alkermes, Inc. gave up 3,183 shares (to pay taxes)
- 4 Shares withheld for taxes EVP R&D, Chief Medical Officer gave up 15,280 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CLO, Alkermes, Inc. gave up 8,483 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 8,137 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Shares withheld for taxes Director gave up 1,000 shares (to pay taxes)
- 8-K Event Executive or director change
Page 16 of 97 · 1,927 filings